Respimat

Edit links
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by The Eloquent Peasant (talk | contribs) at 20:33, 11 May 2020 (Adding local short description: "Drug delivery device used for the treatment of respiratory conditions", overriding Wikidata description "drug delivery device" (Shortdesc helper)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Respimat, also known as Respimat Soft Mist Inhaler, is a drug delivery device used for the treatment of asthma, chronic obstructive pulmonary disease (COPD), and other respiratory conditions.

Its developer, Boehringer Ingelheim, is currently[when?] conducting approved in the U.S. with a variety of their products, such as tiotropium and ipratropium/salbutamol. According to the manufacturer, the reusability of the inhaler reduces its carbon footprint by 71%.[1]

References

  1. ^ "First reusable, propellant-free inhaler launched to cut plastic waste". Pharmaceutical Journal. 17 September 2019. Retrieved 19 November 2019.

Sources

Stub icon

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Respimat&oldid=956160979"